Drug-Target Information
Drug Name Target Name Drug Type Target Type Source Drug MeSHID Interaction Score Drug Status Target Action
ravulizumab complement c5 biotech Successful target TTD , drugbank , DGIDB Paroxysmal nocturnal hemoglobinuria[MeSHID:D006457]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 9.09 approved,investigational inhibitor
ravulizumab complement c5 biotech Successful target TTD , drugbank , DGIDB Paroxysmal nocturnal hemoglobinuria[MeSHID:D006457]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Coronavirus Infections[MeSHID:D018352]
Disease[MeSHID:D004194]		 9.09 approved,investigational inhibitor
click here to return to the previous page